Aeglea Biotherapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $230k | 6.1k | 37.93 |